Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

IDEAYA Biosciences Inc. (IDYA)

12.19   0.56 (4.82%) 09-29 00:39
Open: 11.69 Pre. Close: 11.63
High: 12.42 Low: 11.51
Volume: 47,302 Market Cap: 354M
IDEAYA Biosciences, Inc. engages in the research and development of oncology-focused precision medicine. The company is headquartered in South San Francisco, California and currently employs 50 full-time employees. The firm focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The Company’s product candidate is IDE196, a protein kinase C (PKC), inhibitor for genetically defined cancers having GNAQ or GNA11 gene mutations. Its preclinical pipeline includes multiple synthetic lethality programs, including against methionine adenosyltransferase 2a (MAT2A) in tumor cells having methylthioadenosine phosphorylase (MTAP) gene deletion; Pol-theta, in tumors with genetic mutations in homologous recombination deficiency (HRD), including breast carcinoma (BRCA ) mutations; poly adenosine diphosphate-ribose glycohydrolase (PARG), in tumors with genetic mutations in BRCA or base excision repair, and WRN, in high microsatellite instability tumors (MSI) tumors.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 12.468 - 12.538 12.538 - 12.602
Low: 11.335 - 11.422 11.422 - 11.501
Close: 12.059 - 12.19 12.19 - 12.31

Technical analysis

as of: 2020-09-28 4:33:52 PM
Overall:       
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 15.07     One year: 16.39
Support: Support1: 11.08    Support2: 9.22
Resistance: Resistance1: 12.90    Resistance2: 14.03
Pivot: 12.38
Moving Average: MA(5): 11.85     MA(20): 12.31
MA(100): 11.45     MA(250): 8.60
MACD: MACD(12,26): -0.01     Signal(9): 0.08
Stochastic oscillator: %K(14,3): 24.67     %D(3): 22.66
RSI: RSI(14): 50.19
52-week: High: 19.97  Low: 2.95  Change(%): 34.3
Average Vol(K): 3-Month: 18358  10-Days: 18043

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
IDYA has closed above bottom band by 40.5%. Bollinger Bands are 45% narrower than normal. The narrow width of the bands suggests low volatility as compared to IDYA's normal range. The bands have been in this narrow range for 35 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Mon, 28 Sep 2020
Northland Securities Remains a Buy on IDEAYA Biosciences (IDYA) - Analyst Ratings

Thu, 24 Sep 2020
The Daily Biotech Pulse: Gilead's $7.25B Debt Offering, Lexicon Deleverages, Taysha Gene Therapies Prices IPO - Benzinga

Thu, 24 Sep 2020
IDEAYA and Pfizer Expand Clinical Trial Collaboration and Supply Agreement to Evaluate Clinical Combination of IDE196 and Crizotinib in Solid Tumors Harboring GNAQ or GNA11 Mutations - PRNewswire

Mon, 31 Aug 2020
IDEAYA to Participate in Upcoming September 2020 Investor Relations Events - PRNewswire

Wed, 12 Aug 2020
IDEAYA Biosciences, Inc. Reports Second Quarter 2020 Financial Results and Provides Business Update - BioSpace

Wed, 12 Aug 2020
IDEAYA Biosciences, Inc. (IDYA) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance

Financial Analysis

Growth n/a
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability n/a
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 29
Shares Float (M) 15
% Held by Insiders 26.03
% Held by Institutions 52.74
Shares Short (K) 575
Shares Short P. Month (K) 594

Stock Financials

EPS -2.260
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 6.330
Profit Margin
Operating Margin
Return on Assets (ttm) -18.9
Return on Equity (ttm) -31.6
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -1.608
Qtrly Earnings Growth
Operating Cash Flow (M) -42
Levered Free Cash Flow (M) -26

Stock Valuations

PE Ratio -5.39
PEG Ratio
Price to Book value 1.93
Price to Sales
Price to Cash Flow -8.34

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.